These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4515633)

  • 41. [Plasma viscosity, immunoglobulins and fibrinogen in cirrhosis of the liver].
    Bungert HJ; Leonhardt H
    Dtsch Med Wochenschr; 1972 Dec; 97(51):1976-9. PubMed ID: 4641795
    [No Abstract]   [Full Text] [Related]  

  • 42. Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver.
    Ballmer PE; Reichen J; McNurlan MA; Sterchi AB; Anderson SE; Garlick PJ
    Hepatology; 1996 Jul; 24(1):53-9. PubMed ID: 8707282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Chronic fibrinolysis in alcoholic cirrhosis].
    Thuot C; Perron L
    Union Med Can; 1974 Aug; 103(8):1400-4. PubMed ID: 4848276
    [No Abstract]   [Full Text] [Related]  

  • 44. The fibrinolytic enzyme system in acute and chronic liver injury.
    Mowat NA; Brunt PW; Ogston D
    Acta Haematol; 1974; 52(5):289-93. PubMed ID: 4141562
    [No Abstract]   [Full Text] [Related]  

  • 45. [State of the coagulation and anticoagulation systems of the blood in chronic hepatitis and liver cirrhosis].
    Mokhov VM
    Ter Arkh; 1971 Jul; 43(6):73-6. PubMed ID: 5125990
    [No Abstract]   [Full Text] [Related]  

  • 46. [Behavior of the serum electrolytes sodium and potassium in patients with cholelithiasis with reference to pathologic changes in the liver].
    Schmauss AK; Gerloff D; Poley FW
    Z Gesamte Inn Med; 1971 May; 26(10):327-31. PubMed ID: 5131401
    [No Abstract]   [Full Text] [Related]  

  • 47. Significance of intravascular coagulation and fibrinolysis in acute hepatic failure.
    Hillenbrand P; Parbhoo SP; Jedrychowski A; Sherlock S
    Scand J Gastroenterol Suppl; 1973; 19():133-4. PubMed ID: 4515635
    [No Abstract]   [Full Text] [Related]  

  • 48. [Albumin turbidity reaction in serum. Site of reaction in albumin peak after fractionation on Sephadex G-100 (author's transl)].
    Spízek J; Fassati P; Erbenová L; Fassati M
    Cas Lek Cesk; 1974 Sep; 113(36):1087-91. PubMed ID: 4408523
    [No Abstract]   [Full Text] [Related]  

  • 49. [Hemostasis disorders in liver cirrhosis. 1. Pathogenesis, diagnosis].
    Neidhardt B; Schricker KT
    Fortschr Med; 1982 Apr; 100(14):626-30. PubMed ID: 7084848
    [No Abstract]   [Full Text] [Related]  

  • 50. [Spectrum of free and protein aminoacids of the blood in patients with chronic hepatitis and liver cirrhosis].
    Manto IE; Manto EI
    Vrach Delo; 1977 Sep; (9):93-5. PubMed ID: 919495
    [No Abstract]   [Full Text] [Related]  

  • 51. Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4.
    Panasiuk A; Prokopowicz D; Zak J; Matowicka-Karna J; Osada J; Wysocka J
    Hepatogastroenterology; 2001; 48(39):818-22. PubMed ID: 11462931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.
    Stein SF; Harker LA
    J Lab Clin Med; 1982 Feb; 99(2):217-30. PubMed ID: 7061918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Correlation between fibrinolysis and the indexes of blood coagulation and of hepatic damage in chronic liver disease and liver cirrhosis].
    Craveri A; Cerrini R; Repaci G; Saracino F
    G Clin Med; 1968 Dec; 49(12):1326-53. PubMed ID: 4242987
    [No Abstract]   [Full Text] [Related]  

  • 54. [Activity of serum trypsin in patients with chronic hepatitis and liver cirrhosis as an index of extrasecretory function of the pancreas].
    Lukanev GD
    Vrach Delo; 1968 Oct; 10():30-3. PubMed ID: 5740323
    [No Abstract]   [Full Text] [Related]  

  • 55. Cellular sensitivity to native type IV collagen in primary biliary cirrhosis.
    Suou T; Ago H; Sawada H; Hirayama C
    Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):275-91. PubMed ID: 8480075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hepatogenic diabetes].
    Vido I; Valovicová E; Belajová E
    Munch Med Wochenschr; 1969 Sep; 111(38):1898-902. PubMed ID: 5395276
    [No Abstract]   [Full Text] [Related]  

  • 57. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Retention of bromsulphalein in the serum during various stages of activity in chronic hepatitis and liver cirrhosis].
    Vido I; Wildhirt E
    Cesk Gastroenterol Vyz; 1968 Oct; 22(7):433-7. PubMed ID: 5703995
    [No Abstract]   [Full Text] [Related]  

  • 59. [At II in liver diseases. Comparison between immunological determination and that with chromogenic substrate].
    Carmignoto F; Schivo P; Zotti S; Ceriotti G
    Arch Sci Med (Torino); 1980; 137(3):467-70. PubMed ID: 6786256
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C.
    Luo JC; Hwang SJ; Chang FY; Chu CW; Lai CR; Wang YJ; Lee PC; Tsay SH; Lee SD
    Hepatogastroenterology; 2002; 49(44):478-81. PubMed ID: 11995477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.